Showing results (131-140 of 389) with videos related to
Sort By:
Pageof 39
Annals of Neurology|September 28, 1998
Programmed cell death: does it play a role in Parkinson's disease?R E Burke, N G KholodilovNeuroscience Letters|December 15, 1989
Autoradiographic evidence of [3H]neurotensin binding changes in discrete regions of brain in the rat model of persistent spasmodic dyskinesia induced by iminodipropionitrileS Przedborski, M Wright, S Fahn, et al.Brain Research|December 18, 1989
Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrileS Przedborski, M Wright, S Fahn, et al.Southern Medical Journal|September 1, 1988
Clonazepam, haloperidol, and clonidine in tic disordersD D Troung, S Bressman, H Shale, et al.Annals of Neurology|June 1, 1983
Lithium interferes with reserpine-induced dopamine depletionA Reches, M N Hassan, V Jackson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 1998
Outcome of selective ramisectomy for botulinum toxin resistant torticollisB Ford, E D Louis, P Greene, et al.Neuroscience Letters|August 14, 1990
Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN)S Przedborski, M Wright, S Fahn, et al.Neurology|March 17, 2000
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutationY Furukawa, O Hornykiewicz, S Fahn, et al.Neuroscience Letters|October 8, 1986
Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockadeM Traub, A Reches, H R Wagner, et al.Handbook of Clinical Neurology|October 11, 2016
Inpatient treatment for functional neurologic disordersD T Williams, K Lafaver, A Carson, et al.Pageof 39